These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 6229053

  • 1. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer patients.
    Balch CM, Dougherty PA, Cloud GA, Tilden AB.
    Surgery; 1984 Jan; 95(1):71-7. PubMed ID: 6229053
    [Abstract] [Full Text] [Related]

  • 2. Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients.
    Balch CM, Dougherty PA, Tilden AB.
    Ann Surg; 1982 Dec; 196(6):645-50. PubMed ID: 6216863
    [Abstract] [Full Text] [Related]

  • 3. Indomethacin enhancement of immunocompetence in melanoma patients.
    Tilden AB, Balch CM.
    Surgery; 1981 Jul; 90(1):77-84. PubMed ID: 6972628
    [Abstract] [Full Text] [Related]

  • 4. Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppression.
    Tilden AB, Balch CM.
    Surgery; 1982 Sep; 92(3):528-32. PubMed ID: 6287658
    [Abstract] [Full Text] [Related]

  • 5. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
    Fischer A, Durandy A, Griscelli C.
    J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
    [Abstract] [Full Text] [Related]

  • 6. The role of prostaglandin E2 in immune suppression following injury.
    Grbic JT, Mannick JA, Gough DB, Rodrick ML.
    Ann Surg; 1991 Sep; 214(3):253-62; discussion 262-3. PubMed ID: 1929607
    [Abstract] [Full Text] [Related]

  • 7. Immune dysfunction in primary biliary cirrhosis. II. Increased production of prostaglandin E.
    Chiricolo M, Lenzi M, Bianchi F, Franceschi C, Bartolini G, Orlandi M, Tomasi V, Licastro F.
    Scand J Immunol; 1989 Sep; 30(3):363-7. PubMed ID: 2789430
    [Abstract] [Full Text] [Related]

  • 8. Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell.
    Wanebo HJ, Riley T, Katz D, Pace RC, Johns ME, Cantrell RW.
    Cancer; 1988 Feb 01; 61(3):462-74. PubMed ID: 2962730
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.
    Awara W, Hillier K, Jones D.
    Immunology; 1986 Dec 01; 59(4):557-62. PubMed ID: 3468061
    [Abstract] [Full Text] [Related]

  • 10. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP, Harris JE.
    J Biol Response Mod; 1984 Oct 01; 3(5):533-40. PubMed ID: 6239013
    [Abstract] [Full Text] [Related]

  • 11. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
    Koster FT, Williams JC, Goodwin JS.
    J Immunol; 1985 Aug 01; 135(2):1067-72. PubMed ID: 2409135
    [Abstract] [Full Text] [Related]

  • 12. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
    Wanebo HJ, Pace R, Hargett S, Katz D, Sando J.
    Cancer; 1986 Feb 01; 57(3):656-62. PubMed ID: 3484660
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients.
    Han T, Nemoto T, Ledesma EJ, Bruno S.
    Int J Immunopharmacol; 1983 Feb 01; 5(1):11-5. PubMed ID: 6601630
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
    Goodwin JS, Messner RP, Peake GT.
    J Clin Invest; 1978 Oct 01; 62(4):753-60. PubMed ID: 701474
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma.
    Murray JL, Kollmorgen GM.
    J Clin Immunol; 1983 Jul 01; 3(3):268-76. PubMed ID: 6224806
    [Abstract] [Full Text] [Related]

  • 16. Sensitivity of lymphocytes to prostaglandin E2 increases in subjects over age 70.
    Goodwin JS, Messner RP.
    J Clin Invest; 1979 Aug 01; 64(2):434-9. PubMed ID: 457862
    [Abstract] [Full Text] [Related]

  • 17. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
    Licastro F, Lenzi M, Chiricolo M, Davis LJ, Cassani F, Bianchi F, Franceschi C.
    J Clin Lab Immunol; 1987 May 01; 23(1):19-23. PubMed ID: 3612758
    [Abstract] [Full Text] [Related]

  • 18. Augmentation of prostaglandin and thromboxane production in vitro by monocytes exposed to histamine-induced suppressor factor (HSF).
    Rocklin RE, Kiselis I, Beer DJ, Rossi P, Maggi F, Bellanti JA.
    Cell Immunol; 1983 Apr 01; 77(1):92-8. PubMed ID: 6573232
    [Abstract] [Full Text] [Related]

  • 19. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.
    Schambelan M, Blake S, Sraer J, Bens M, Nivez MP, Wahbe F.
    J Clin Invest; 1985 Feb 01; 75(2):404-12. PubMed ID: 3156147
    [Abstract] [Full Text] [Related]

  • 20. Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
    Mizushima Y, Wepsic HT, Yamamura Y, Desilva MA.
    Clin Exp Immunol; 1984 Aug 01; 57(2):371-9. PubMed ID: 6235988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.